Government legislation, consumer trends and environmental concerns are compelling the development of bioplastics and natural fibers in markets including food packaging, automotive, building/construction, textiles, agriculture, sports & leisure and consumer goods. Biocomposites based on these materials offer significant advantages over incumbent synthetic materials including lightweighting, sustainability and reduced carbon footprint. Natural fibers are also abundant and low-cost. The bioplastics and natural fibers market will witness good growth through to 2030, with excellent opportunities for large producers and start ups.
The report provides an in depth analysis of the bioplastics and natural fibers market by applications and bioplastic and natural fiber type.
Report contents include:
- Market trends and drivers in the bioplastics and natural fibers market.
- Production estimates by bioplastics and natural fibers producers, types, market and regions.
- Impact of COVID-19.
- Challenges for the bioplastics and natural fibers market.
- Advantages and disadvantages of the bioplastics and natural fibers over synthetic plastics.
200 pages •
By The Business Research Company
• May 2022
Major players in the polymer biomaterials market are BASF, Corbion, Zimmer Biomet, Royal DSM, Koninklijke DSM, Covestro, Evonik Industries, Starch Medical, Victrex, and W.L. Gore and Associate. The global polymer biomaterial market is expected to grow from $47.27 billion in 2021 to $55.96 billion in 2022 at a compound annual...
The global nanocellulose market is estimated to be valued at USD 756.80 million in 2022, and is expected to register a CAGR of 21.56% during the forecast period of 2022-2027. The market was negatively affected due to COVID-19. Manufacturing activities were halted due to supply chain disruptions and labor shortages or as a protective measure...
The global antifibrinolytic drugs market reached a value of US$ 15.46 Billion in 2021. Looking forward, the analyst expects the market to reach a value of US$ 20.46 Billion by 2027, exhibiting a CAGR of 4.60% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the...
The global active calcium silicate market reached a value of US$ 311.5 Million in 2021. Looking forward, the analyst expects the market to reach a value of US$ 425.1 Million by 2027, exhibiting a CAGR of 5.10% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as...
The global neuromodulation market reached a value of US$ 6.05 Billion in 2021. Looking forward, the analyst expects the market to reach a value of US$ 11.84 Billion by 2027, exhibiting a CAGR of 11.50% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect...
237 pages •
By Global Industry Analysts
• Jul 2022
Abstract: What`s New for 2022? - Global competitiveness and key competitor percentage market shares - Market presence across multiple geographies - Strong/Active/Niche/Trivial - Online interactive peer-to-peer collaborative bespoke updates - Access to our digital archives and MarketGlass...
492 pages •
By Global Industry Analysts
• Jul 2022
Abstract: What`s New for 2022? - Global competitiveness and key competitor percentage market shares - Market presence across multiple geographies - Strong/Active/Niche/Trivial - Online interactive peer-to-peer collaborative bespoke updates - Access to our digital archives and MarketGlass...
Global Dental Bone Graft Substitute Market, By Type (Synthetic Bone Graft, Xenograft, Allograft, Autograft, Alloplast, Others), By Material (Collagen, Human Cell Source, Animal Source, Others), By Mechanism (Osteoconduction, Osteoinduction, Osteopromotion, Osteogenesis), By Product (Bio OSS, Osteograf, Grafton) By Application (Socket...
The global bone graft and substitutes market reached a value of US$ 2.8 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 4.0 Billion by 2027, exhibiting a CAGR of 6.2% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect...
200 pages •
By The Business Research Company
• May 2022
Major players in the implantable biomaterials market are Evonik Industries AG, Royal DSM, Zimmer Biomet Holdings, Carpenter Technology Corporation, Collagen Matrix, Corbion, BASF SE, Invibio Ltd., and Celanese Corporation. The global implantable biomaterials market is expected to grow from $101.91 billion in 2021 to $113.64 billion...
Biomaterial
World
APAC
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.